Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,6,0.98 [0.89-1.08],0.662916540176877
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,6,0.96 [0.88-1.04],0.342141493491651
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,6,1.05 [0.88-1.26],0.569570174631918
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,6,1.01 [0.88-1.17],0.843096139756798
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,6,0.97 [0.26-3.66],0.965690937838748
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,6,1.04 [0.81-1.33],0.744489814575254
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,6,0.20 [0.05-0.74],0.0156228595875851
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,6,0.97 [0.60-1.56],0.891758318310567
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,6,0.95 [0.72-1.27],0.742475984811527
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,6,0.97 [0.50-1.88],0.920762015144387
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,6,0.99 [0.84-1.16],0.890610328095057
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,6,1.14 [0.96-1.35],0.129089583741154
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,6,0.94 [0.73-1.22],0.648537940781162
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,6,1.03 [0.71-1.50],0.860574172645414
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,6,1.13 [0.80-1.58],0.492438799378537
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,6,0.92 [0.44-1.91],0.820098126825527
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,6,0.92 [0.65-1.30],0.641185896127862
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,6,1.29 [0.94-1.76],0.114171023088686
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,6,0.97 [0.79-1.20],0.798835846897847
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,6,1.05 [0.73-1.49],0.80692064751231
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,6,1.21 [0.77-1.92],0.404919085673352
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,6,0.96 [0.77-1.21],0.745238860996792
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,6,0.83 [0.59-1.17],0.293033930913999
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,6,0.84 [0.62-1.15],0.28392929036036
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,6,1.01 [0.64-1.59],0.979716000772084
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,6,1.17 [0.87-1.58],0.289033620694826
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,6,0.89 [0.76-1.03],0.10939048866769
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,6,1.00 [0.90-1.12],0.93206544629542
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,6,0.85 [0.66-1.08],0.181805196994606
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,6,0.96 [0.83-1.11],0.566316971180449
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,6,0.96 [0.84-1.09],0.522215941895845
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,6,0.66 [0.33-1.32],0.241700072352537
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,6,1.00 [0.88-1.14],0.991551512112449
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,6,1.40 [0.93-2.11],0.106652013607856
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,6,0.69 [0.41-1.14],0.147592513012093
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,6,1.46 [0.73-2.92],0.28308560752434
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,6,1.20 [0.73-1.96],0.470791518808862
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,6,1.00 [0.61-1.66],0.990489829741026
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,6,1.03 [0.80-1.32],0.812829687300783
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,6,0.90 [0.70-1.14],0.376878203900137
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,6,1.24 [0.82-1.86],0.302995582809744
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,6,1.20 [0.95-1.53],0.12302637080933
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,6,1.04 [0.84-1.28],0.728427604964193
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,6,0.98 [0.91-1.05],0.61389625425942
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,6,1.05 [0.98-1.12],0.188411195950183
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,6,1.04 [0.93-1.16],0.517868318143331
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,6,0.91 [0.79-1.04],0.161899253521699
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,6,0.96 [0.76-1.23],0.753753005281586
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,6,1.10 [0.81-1.50],0.534482974420305
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,6,0.98 [0.89-1.07],0.596033568603096
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,Inverse variance weighted,6,1.47 [0.96-2.26],0.0769106850889669
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,6,0.92 [0.74-1.16],0.495509684625009
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,6,0.99 [0.65-1.49],0.951769686581608
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,6,0.95 [0.57-1.60],0.850776842262513
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,6,0.98 [0.84-1.14],0.780881866089781
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,Inverse variance weighted,6,1.07 [0.68-1.68],0.782549972090987
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,6,1.07 [0.94-1.22],0.304170657805645
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,6,0.87 [0.57-1.32],0.499631326568127
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,6,1.07 [0.97-1.20],0.188605032337552
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,6,0.93 [0.71-1.22],0.596741460994137
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,6,0.77 [0.57-1.04],0.0872939386444702
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,6,0.98 [0.77-1.24],0.872363548905255
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,6,0.81 [0.46-1.43],0.470867505150068
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,6,1.07 [0.62-1.85],0.79525325652169
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,6,0.94 [0.83-1.06],0.298918973846586
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,6,0.94 [0.63-1.39],0.745230662189105
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,6,0.93 [0.84-1.03],0.173558684098503
